Search

everythinglearnresearchcommunity

for

Search:↓

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Nanotechnology could improve scar treatment but needs more development.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Biological therapy boosts the immune system to effectively fight melanoma.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Nanocarriers show promise for improving skin drug delivery in treating skin conditions.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

CD44 signaling can help heal wounds without scars.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Apremilast did not work for treating severe alopecia areata.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Nilotinib may cause gray hair to return to its original color.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.